Checkpoint Trends Ltd
Checkpoint Trends Limited (Formerly known as Rubra Medicaments Ltd) is into the business of consultancy.The main object of the company is to cater to all categories of clients providing all types of consulting services.The company is headquartered in Mumbai.[1]
- Market Cap ₹ 5.12 Cr.
- Current Price ₹ 9.36
- High / Low ₹ 12.4 / 3.76
- Stock P/E 171
- Book Value ₹ 0.97
- Dividend Yield 0.00 %
- ROCE 3.39 %
- ROE 5.83 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Stock is trading at 9.66 times its book value
- Company has a low return on equity of -5.41% over last 3 years.
- Company has high debtors of 229 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.20 | 0.31 | 2.30 | 0.59 | 0.99 | 0.49 | 2.01 | 1.16 | 1.13 | |
0.05 | 0.06 | 0.07 | 0.21 | 0.28 | 2.33 | 0.77 | 0.97 | 0.48 | 2.03 | 1.24 | 1.10 | |
Operating Profit | -0.05 | -0.06 | -0.07 | -0.01 | 0.03 | -0.03 | -0.18 | 0.02 | 0.01 | -0.02 | -0.08 | 0.03 |
OPM % | -5.00% | 9.68% | -1.30% | -30.51% | 2.02% | 2.04% | -1.00% | -6.90% | 2.65% | |||
0.00 | 0.00 | -3.00 | 0.00 | 0.00 | -0.13 | 0.17 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Profit before tax | -0.05 | -0.06 | -3.07 | -0.01 | 0.03 | -0.16 | -0.01 | 0.05 | 0.01 | -0.02 | -0.08 | 0.02 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 20.00% | 0.00% | 50.00% | 0.00% | -50.00% |
-0.05 | -0.06 | -3.07 | -0.01 | 0.03 | -0.16 | -0.01 | 0.03 | 0.01 | -0.04 | -0.08 | 0.03 | |
EPS in Rs | -0.09 | -0.11 | -5.61 | -0.02 | 0.05 | -0.29 | -0.02 | 0.05 | 0.02 | -0.07 | -0.15 | 0.05 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 14% |
3 Years: | 32% |
TTM: | -3% |
Compounded Profit Growth | |
---|---|
10 Years: | 10% |
5 Years: | 17% |
3 Years: | 44% |
TTM: | 138% |
Stock Price CAGR | |
---|---|
10 Years: | 16% |
5 Years: | 19% |
3 Years: | 32% |
1 Year: | 89% |
Return on Equity | |
---|---|
10 Years: | -3% |
5 Years: | -2% |
3 Years: | -5% |
Last Year: | 6% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 |
Reserves | -1.94 | -2.00 | -5.08 | -5.08 | -5.05 | -4.87 | -4.89 | -4.85 | -4.85 | -4.88 | -4.97 | -4.94 |
0.17 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.00 | |
0.07 | 0.08 | 0.07 | 0.06 | 0.11 | 0.21 | 0.12 | 0.13 | 0.29 | 0.26 | 0.01 | 0.40 | |
Total Liabilities | 3.77 | 3.78 | 0.46 | 0.45 | 0.53 | 0.81 | 0.70 | 0.75 | 0.91 | 0.85 | 0.66 | 0.93 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 | 0.06 | 0.07 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
3.77 | 3.78 | 0.46 | 0.45 | 0.53 | 0.81 | 0.68 | 0.73 | 0.90 | 0.84 | 0.60 | 0.86 | |
Total Assets | 3.77 | 3.78 | 0.46 | 0.45 | 0.53 | 0.81 | 0.70 | 0.75 | 0.91 | 0.85 | 0.66 | 0.93 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -0.05 | -0.08 | -0.01 | 0.04 | 0.18 | -0.03 | 0.12 | 0.52 | -0.50 | 0.01 | -0.02 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.05 | 0.06 | -0.23 | -0.02 | 0.02 | 0.00 | -0.17 | -0.26 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash Flow | 0.00 | 0.01 | -0.31 | -0.03 | 0.06 | 0.18 | -0.20 | -0.14 | 0.52 | -0.50 | 0.01 | -0.02 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 36.50 | 23.55 | 53.96 | 179.41 | 106.92 | 163.88 | 121.67 | 135.30 | 229.34 | |||
Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 36.50 | 23.55 | 53.96 | 179.41 | 106.92 | 163.88 | 121.67 | 135.30 | 229.34 | |||
Working Capital Days | 18.25 | -35.32 | 36.50 | 259.83 | 221.21 | 59.59 | 98.06 | 176.21 | 145.35 | |||
ROCE % | -1.35% | -1.62% | -3.42% | -2.56% | 7.41% | 25.49% | -30.51% | 3.33% | 1.61% | -3.31% | -12.90% | 3.39% |
Documents
Announcements
- Closure of Trading Window 27 Jun
- Announcement under Regulation 30 (LODR)-Newspaper Publication 29 May
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
25 May - Audit Report for the year ended March 31, 2024
-
Announcement under Regulation 30 (LODR)-Change in Management
25 May - Cessation of Managing Director 2. Reappointment of Independent director
- Audited Financial Result For The Year Ended March 31, 2024 25 May
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Name Change
In FY23, a Special Resolution was passed by the for change of name of the company
from Rubra Medicaments Limited to Checkpoint Trends Limited.[1]